Atlas Trials

A Study of GRN163L With Paclitaxel and Bevacizumab to Treat Patients With Locally Recurrent Or Metastatic Breast Cancer

Clinical trial NCT00732056 · COMPLETED

Trial details

NCT number
NCT00732056
Sponsor
Geron Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2008-07-01
Primary completion
2011-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.